Lifecore Stock: Getting Closer To Massive Improvements In Earnings Power (NASDAQ:LFCR)

Remitski/iStock via Getty Images The following segment was excerpted from this fund letter. Lifecore Biomedical (NASDAQ:LFCR) Lifecore, discussed above, is our fill-finish CDMO that also has a dominant position in pharmaceutical grade hyaluronic acid production. The company is presently bringing on additional capacity that was planned for ~4 years ago. You likely recall that over…

Read More

DraftKings: 2024 Could See A Transaction As Positive EBITDA Gets Closer (NASDAQ:DKNG)

Seth Love DraftKings Inc. (NASDAQ:DKNG) has bullish prospects for 2024, but investors need to consider entry of two deep-pocketed new competitors: ESPNBet and Fanatics. DKNG will turn profitable next year propelled by double-digit sales growth and continued narrowing of promotional spend–unless newbies swamp the sector with crazy free bet promotions. The FanDuel parent Flutter Entertainment…

Read More

5% Yield And Up To 40% Undervalued – A Closer Look At Prudential (NYSE:PRU)

Altayb Introduction It’s time to discuss a company I’ve never discussed before. That company is Prudential Financial, Inc. (NYSE:PRU). The company is a global financial services leader and a prominent active global investment manager, managing a substantial $1.4 trillion in assets as of December 31, 2022. Prudential Financial Its expansive operations extend across the United…

Read More

FTQI: A Change In 2022 Has Put It Closer To Competitors

Zerbor This article series aims at evaluating ETFs (exchange-traded funds) regarding the relative past performance of their strategies and metrics of their current portfolios. Reviews with updated data are posted when necessary. FTQI strategy and portfolio First Trust Nasdaq BuyWrite Income ETF (NASDAQ:FTQI) is an actively managed fund launched on 1/6/2014. It currently holds a…

Read More

Dynavax: Analyzing Mixed Signals, Closer Look At Heplisav-B (NASDAQ:DVAX)

PepeLaguarda/iStock via Getty Images At a Glance Building on my previous analysis of Dynavax Technologies (NASDAQ:DVAX), the landscape has shifted subtly. HEPLISAV-B sales continue to be a bright spot, but new elements like insider selling activities have entered the equation. Financially, the picture remains complex: revenues have declined year-over-year, yet the rise in HEPLISAV-B sales,…

Read More

Bitcoin Nodes Now One Step Closer to Instant Sync

Bitcoin light clients are now able to sync to the tip of the blockchain nearly instantly, thanks to a new development enabled by bitcoin startup ZeroSync and their work in zero-knowledge (ZK) proofs. Ultimately, ZeroSync seeks to enable full nodes to do the same. ZK proofs allow a prover to generate a short mathematical statement…

Read More